Finzati - Logo
RYTM logo

Rhythm Pharmaceuticals, Inc.

RYTMBiotechnology
$102.74
-2.15 (-2.05%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$7.05B
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 160.3%Healthy liquidity · 4.41Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:38 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$102.74
Change-2.05%
Shares Out68.59M
Market Cap$7.05B
Enterprise Value$6.72B
52W Range74.50 - 122.20
Beta1.88
P/E-34.32
P/S29.37
P/B32.43
P/FCF-66.29
EV/Sales27.99

Investment DNA

How strong this company looks for long-term investors

40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
60/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score
Positive revenue growth · 160.3%Healthy liquidity · 4.41Weak profitability

Analyst view

Analyst sentiment and price target

RYTM
Analyst sentiment
Based on 22 analyst votes · 2026-09-05
100/100
Bullish
Bullish
22
Hold
0
Bearish
0
Price Target
2026-08-06
Low
$125.00
Mean
$144.43
Median
$143.00
High
$160.00

Company Overview

IPO: 10/9/2017
Industry: Biotechnology
P/B i: 32.43
Debt / Equity i: 1.77
Operating Margin: -101.19%
Net Margin: -103.57%
ROE i: -
ROIC: -

Financial Health

Score12 / 20
Debt / Equity: 1.77
Current Ratio: 4.41
Quick Ratio: 4.16
Status: Good

Insider Transactions

Recent executive and insider activity

Garfield Alastair
Transaction: 07/01/2026
SELL
Change
-4,445
Price
Not reported
Filing
07/02/2026
Type
SELL
Garfield Alastair
Transaction: 07/01/2026
SELL
Change
-2,150
Price
$110.41
Filing
07/02/2026
Type
SELL
GOOD JENNIFER L
Transaction: 06/24/2026
BUY
Change
+2,324
Price
Not reported
Filing
06/25/2026
Type
BUY